Accessibility Tools

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment. Retinal vein occlusion is one of the most common blinding conditions in the United States; without treatment, central retinal vein occlusion (CRVO), the most severe type of retinal vein occlusion often leads to significant and permanent vision loss. A report on five-year outcomes of the Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2), was published April 21 in American Journal of Ophthalmology. SCORE2 was funded in part by the National Eye Institute (NEI), a part of the National Institutes of Health.

Source: News Medical Life Sciences

Read More

Torrance

23000 Crenshaw Blvd, Suite 100
Torrance, CA 90505

Monday to Friday 8am - 5pm

Huntington Beach

7777 Edinger Ave, Suite 234
Huntington Beach, CA 92647

Monday to Friday 8am - 5pm